Mariana Baz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Respiratory Tract

Silver Nanoparticles

Clinical Evaluation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Silveira, Florencia García, Gabriel García, José A Chabalgoity, Silvina Rossi, Mariana Baz
Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice. Vaccines 12 (8) (2024)
Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Paulina Koszalka, Kanta Subbarao, Mariana Baz
Preclinical and clinical developments for combination treatment of influenza. PLoS pathogens 18 (5) (2022)
Mariana Rivera-Patron, María Moreno, Mariana Baz, Paulo Michel Roehe, Samuel Paulo Cibulski, Fernando Silveira
ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines. Vaccines 9 (11) (2021)